GTAM
Global Trust Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253K | Sell |
568
-65
| -10% | -$29K | 0.14% | 136 |
|
|
2025
Q1 | $307K | Sell |
633
-14
| -2% | -$6.78K | 0.19% | 114 |
|
|
2024
Q4 | $261K | Sell |
647
-390
| -38% | -$157K | 0.1% | 148 |
|
|
2024
Q3 | $482K | Buy |
1,037
+220
| +27% | +$102K | 0.18% | 111 |
|
|
2024
Q2 | $383K | Sell |
817
-15
| -2% | -$7.03K | 0.15% | 119 |
|
|
2024
Q1 | $348K | Sell |
832
-830
| -50% | -$347K | 0.14% | 128 |
|
|
2023
Q4 | $676K | Sell |
1,662
-85
| -5% | -$34.6K | 0.3% | 79 |
|
|
2023
Q3 | $608K | Sell |
1,747
-75
| -4% | -$26.1K | 0.29% | 81 |
|
|
2023
Q2 | $641K | Sell |
1,822
-15
| -0.8% | -$5.28K | 0.29% | 79 |
|
|
2023
Q1 | $579K | Buy |
1,837
+100
| +6% | +$31.5K | 0.28% | 82 |
|
|
2022
Q4 | $502K | Sell |
1,737
-315
| -15% | -$91K | 0.25% | 88 |
|
|
2022
Q3 | $594K | Buy |
2,052
+50
| +2% | +$14.5K | 0.31% | 75 |
|
|
2022
Q2 | $564K | Sell |
2,002
-1,050
| -34% | -$296K | 0.28% | 88 |
|
|
2022
Q1 | $796K | Buy |
3,052
+2,868
| +1,559% | +$748K | 0.33% | 68 |
|
|
2021
Q4 | $40K | Buy |
184
+115
| +167% | +$25K | 0.02% | 271 |
|
|
2021
Q3 | $13K | Hold |
69
| – | – | 0.01% | 309 |
|
|
2021
Q2 | $14K | Buy |
+69
| New | +$14K | 0.01% | 305 |
|
|
2020
Q3 | – | Sell |
-1,275
| Closed | -$370K | – | 397 |
|
|
2020
Q2 | $370K | Sell |
1,275
-875
| -41% | -$254K | 0.26% | 95 |
|
|
2020
Q1 | $499K | Buy |
+2,150
| New | +$499K | 0.39% | 74 |
|
|
2019
Q1 | – | Sell |
-63
| Closed | -$10K | – | 451 |
|
|
2018
Q4 | $10K | Hold |
63
| – | – | 0.01% | 282 |
|
|
2018
Q3 | $12K | Hold |
63
| – | – | 0.01% | 307 |
|
|
2018
Q2 | $11K | Hold |
63
| – | – | 0.01% | 301 |
|
|
2018
Q1 | $10K | Hold |
63
| – | – | 0.01% | 297 |
|
|
2017
Q4 | $9K | Buy |
+63
| New | +$9K | 0.01% | 311 |
|